GTB-3650 is GT Biopharma’s wholly owned second-generation TriKE. It utilizes camelid nanobody technology, with the potential to improve potency and enhance binding affinity. The Phase 1 dose ...
GTB-3650 is GT Biopharma’s wholly owned second-generation TriKE. It utilizes camelid nanobody technology, with the potential to improve potency and enhance binding affinity. The Phase 1 dose ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...
The new phase of the green energy corridor will focus on high-voltage direct current transmission lines, considered the future of energy supply. GEC-III has been on the wish list of the industry as ...
Institute of Chartered Accountants of India (ICAI) has announced a deferment of Phase III and Phase IV of the Peer Review Mandate. The Council has decided to extend the deadlines by 6 and 9 months ...
Institute of Physical Engineering, Brno University of Technology, Technická 2, 616 69 Brno, Czech Republic CEITEC BUT, Brno University of Technology, Purkyňova 123, 612 00 Brno, Czech Republic ...
(Image Credits: Pixabay) AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 J.P. Morgan Healthcare Conference, is set to transform the ...
NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback